Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sander W Tas

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Frontiers in Immunology|December 24, 2015
Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's DiseaseAnne Musters, Amira Assaf, Danielle M Gerlag, et al.
Current Pharmaceutical Design|February 22, 2005
Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapySander W Tas, Philip H J Remans, Kris A Reedquist, et al.
Frontiers in Immunology|December 12, 2019
The Role of Endothelial Cells and TNF-Receptor Superfamily Members in Lymphoid Organogenesis and Function During Health and InflammationKim C M Jeucken, Jasper J Koning, Reina E Mebius, et al.
Autoimmunity Reviews|October 24, 2022
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individualsGiulia Frazzei, Anne Musters, Niek de Vries, et al.
Clinical Case Reports|January 22, 2024
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinibAnna Schuitema, Suzanne I Anjie, Agnies M van Eeghen, et al.
Arthritis Research & Therapy|May 11, 2006
Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammationSander W Tas, Margriet J Vervoordeldonk, Najat Hajji, et al.
Rheumatology Advances in Practice|June 10, 2024
Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 yearsJeffrey R Curtis, Jürgen Wollenhaupt, Sander W Tas, et al.
Frontiers in Immunology|July 8, 2021
A Straightforward Method for 3D Visualization of B Cell Clusters and High Endothelial Venules in Lymph Nodes Highlights Differential Roles of TNFRI and -IIKim C M Jeucken, Jasper J Koning, Jan Piet van Hamburg, et al.
Arthritis and Rheumatism|November 1, 2006
Reduction of proinflammatory cytokine expression in the synovium by targeting IKKbeta in vivo in a rat modelSander W Tas, Najat Hajji, Dirk J Stenvers, et al.
Journal of Neuromuscular Diseases|October 23, 2025
Emerging therapies in idiopathic inflammatory myopathiesMerve Kocyigit, Jan Piet van Hamburg, Eleonora Aronica, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|December 24, 2015
Discovery of Innovative Therapies for Rare Immune-Mediated Inflammatory Diseases via Off-Label Prescription of Biologics: The Case of IL-6 Receptor Blockade in Castleman's DiseaseAnne Musters, Amira Assaf, Danielle M Gerlag, et al.
Current Pharmaceutical Design|February 22, 2005
Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapySander W Tas, Philip H J Remans, Kris A Reedquist, et al.
Frontiers in Immunology|December 12, 2019
The Role of Endothelial Cells and TNF-Receptor Superfamily Members in Lymphoid Organogenesis and Function During Health and InflammationKim C M Jeucken, Jasper J Koning, Reina E Mebius, et al.
Autoimmunity Reviews|October 24, 2022
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individualsGiulia Frazzei, Anne Musters, Niek de Vries, et al.
Clinical Case Reports|January 22, 2024
Symptomatic creatine phosphokinase elevation in a Crohn's disease patient caused by upadacitinibAnna Schuitema, Suzanne I Anjie, Agnies M van Eeghen, et al.
Arthritis Research & Therapy|May 11, 2006
Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammationSander W Tas, Margriet J Vervoordeldonk, Najat Hajji, et al.
Rheumatology Advances in Practice|June 10, 2024
Determinants of tofacitinib discontinuation in adult patients with rheumatoid arthritis during long-term extension studies up to 9.5 yearsJeffrey R Curtis, Jürgen Wollenhaupt, Sander W Tas, et al.
Frontiers in Immunology|July 8, 2021
A Straightforward Method for 3D Visualization of B Cell Clusters and High Endothelial Venules in Lymph Nodes Highlights Differential Roles of TNFRI and -IIKim C M Jeucken, Jasper J Koning, Jan Piet van Hamburg, et al.
Arthritis and Rheumatism|November 1, 2006
Reduction of proinflammatory cytokine expression in the synovium by targeting IKKbeta in vivo in a rat modelSander W Tas, Najat Hajji, Dirk J Stenvers, et al.
Journal of Neuromuscular Diseases|October 23, 2025
Emerging therapies in idiopathic inflammatory myopathiesMerve Kocyigit, Jan Piet van Hamburg, Eleonora Aronica, et al.
Pageof 15